USPTO Examiner HUH VYNN V - Art Unit 3792

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18915848FACIAL BEAUTY MASKOctober 2024March 2025Allow510NoNo
18661059MODULAR IMPLANT DELIVERY AND POSITIONING SYSTEMMay 2024January 2025Allow810YesNo
18611522REAL-TIME TRACKING OF CEREBRAL HEMODYNAMIC RESPONSE (RTCHR) OF A SUBJECT BASED ON HEMODYNAMIC PARAMETERSMarch 2024August 2025Abandon1710NoNo
18441083APPARATUS, SYSTEM AND METHOD FOR CHRONIC DISEASE MONITORINGFebruary 2024June 2025Allow1610NoNo
18407397LOW POWER RECEIVER FOR IN VIVO CHANNEL SENSING AND INGESTIBLE SENSOR DETECTION WITH WANDERING FREQUENCYJanuary 2024June 2025Allow1710YesNo
18511752IMAGE GUIDED VARIABLE SPOT STIMULATION-BASED ELECTROPHYSIOLOGY ASSESSMENT DEVICE TO DETERMINE CHANGES IN THE FUNCTIONAL HEALTH OF BIOLOGICAL SAMPLES DURING DISEASE PROGRESSION AND THERAPYNovember 2023November 2024Allow1210YesNo
18492038SENSING FOR HEART FAILURE MANAGEMENTOctober 2023June 2024Allow800YesNo
18365248ADJUVANT NAIL TREATMENT DEVICEAugust 2023March 2025Allow1930NoNo
18212207BLOOD PUMP SYSTEMJune 2023April 2024Allow1010NoNo
18296045WEARABLE PHYSIOLOGICAL MONITORING SYSTEMS AND METHODSApril 2023December 2025Allow3350YesNo
18116299Variable Human-Safe Electromagnetic Radiation Therapy Systems and MethodsMarch 2023March 2026Abandon3710NoNo
18145426CONTROL DEVICE AND METHOD FOR A HEART PUMPDecember 2022August 2024Allow2020NoNo
17982086NEUROANAL YTIC, NEURODIAGNOSTIC, AND THERAPEUTIC TOOLSNovember 2022April 2024Allow1810YesNo
17997951BLACK LIGHT DEVICE FOR IMPROVING VITAMIN D3 FORMATION IN ANIMALS AND INACTIVATING BACTERIA AND VIRUSESNovember 2022December 2025Abandon3820NoNo
17977413SYSTEMS AND METHODS FOR PRESERVING AND/OR ENHANCING RESPIRATORY FUNCTIONOctober 2022January 2026Allow3910NoNo
17972557METHODS OF SKIN TREATMENT WITH LASER LIGHTOctober 2022February 2025Allow2840YesNo
17971162System for Managing Personal Health Regimens based on Continuously-Adjusted IncentivesOctober 2022July 2024Abandon2110NoNo
17996721CONFIGURABLE OPTICAL APPLICATOROctober 2022February 2024Allow1620YesNo
17910076SYSTEMS AND METHODS FOR ESTIMATING CARDIAC ARRYTHMIASeptember 2022September 2025Abandon3601NoNo
17909870CONTROLLING CYTOCHROME C OXIDASE OF A LIGHT SOURCE BASED ON UV IRRADIATION AMOUNTSeptember 2022December 2024Allow2800NoNo
17929125FACE MASKSeptember 2022July 2025Allow3420YesNo
17896599LASER IRRADIATION DEVICEAugust 2022February 2025Allow3000NoNo
17893104LIGHT THERAPY TREATMENT MODALITY WITH OSCILLATING AND NONOSCILLATING WAVELENGTHSAugust 2022August 2025Allow3601YesNo
17892562PHOTOTHERAPY CAP AND LINING THEREOFAugust 2022April 2025Abandon3110NoNo
17889105MEDICAL DEVICE AND METHOD OF OPERATING A MEDICAL DEVICEAugust 2022September 2025Abandon3720YesNo
17867822LIGHT THERAPY WEARABLEJuly 2022December 2025Abandon4110NoNo
17865820MULTI-MODAL SLEEP SYSTEMJuly 2022January 2025Allow3050YesNo
17861646EXTERNAL AUDITORY CANAL THERAPY DEVICEJuly 2022July 2025Allow3620YesNo
17811387WEARABLE LIGHT STIMULATION SYSTEMS AND METHODSJuly 2022January 2023Allow720YesNo
17781021SYSTEMS AND METHODS OF PROVIDING NETWORKS BASED ON TEXTILESMay 2022May 2025Allow3520YesNo
17747530NECK-HANGING MASSAGING DEVICEMay 2022August 2023Allow1510YesNo
17747588NECK-HANGING MASSAGING DEVICEMay 2022May 2023Allow1210NoNo
17747567NECK-HANGING MASSAGING DEVICEMay 2022June 2023Allow1310YesNo
17744591PHOTOTHERAPYMay 2022April 2024Abandon2331YesNo
17739020ANTENNA ARRANGEMENT FOR WRIST-WORN TRAINING COMPUTERMay 2022June 2025Allow3720YesNo
17737955PHOTOBIOMODULATION METHOD AND SYSTEM FOR INDUCING ACTIVITY OF BRAINDERIVED NERVE GROWTH FACTOR IN HIPPOCAMPAL TISSUEMay 2022January 2025Allow3310YesNo
17714269Wearable Light Therapy DeviceApril 2022June 2023Allow1440YesNo
17754348Glove for detecting multiple physiological parameters and system for detecting risk of hypertension diseaseMarch 2022March 2024Abandon2420NoNo
17708001BIOLOGICAL INFORMATION MONITORING SYSTEMMarch 2022August 2025Allow4020YesNo
17655902PHOTOPLETHYSMOGRAPHY DERIVED BLOOD PRESSURE MEASUREMENT CAPABILITYMarch 2022December 2024Abandon3310NoNo
17690866REAL-TIME METHODS TO ENABLE PRECISION-GUIDED CPR TO IMPROVE NEUROLOGICAL OUTCOME AND PREDICT BRAIN DAMAGE AFTER ISCHEMIC INJURY AND REPERFUSIONMarch 2022January 2025Allow3401YesNo
17635566PHOTOTHERAPY DEVICE AND METHOD OF OPERATION OF PHOTOTHERAPY DEVICEFebruary 2022June 2025Allow3920NoNo
17634310APPARATUS FOR PROCESSING SENSOR SIGNALSFebruary 2022September 2025Abandon4320YesNo
17649709Penis phototherapy deviceFebruary 2022March 2025Allow3810YesNo
17589082EXTERNAL AUDITORY CANAL PHOTOBIOMODULATION AND AUDIO THERAPY DEVICEJanuary 2022August 2025Allow4220YesNo
17562185METHOD FOR PROVIDING CONTROL DATA OF AN EYE SURGICAL LASER OF A TREATMENT APPARATUS BASED ON A PATIENT-SPECIFIC PARAMETER SET; CONTROL DEVICE AS WELL AS TREATMENT APPARATUSDecember 2021May 2025Allow4120YesNo
17561260CONTROLLED POSITION ELECTRODE ARRAYDecember 2021August 2024Allow3230YesNo
17645747CONFOCAL LASER EYE SURGERY SYSTEMDecember 2021March 2024Allow2720NoNo
17558832VFA CARDIAC RESYNCHRONIZATION THERAPYDecember 2021September 2023Allow2020NoNo
17554455ADHESIVE PAD WITH A METALLIC COIL FOR SECURING AN ON-BODY MEDICAL DEVICEDecember 2021June 2025Allow4220YesNo
17546650APPARATUS AND METHOD FOR TREATING SKIN LESIONSDecember 2021May 2025Abandon4110NoNo
17617364EXTERNAL AUDITORY CANAL PHOTOBIOMODULATION DEVICEDecember 2021July 2025Allow4320YesNo
17600647DEVICE FOR BIOSTIMULATING PHOTOTHERAPHYOctober 2021June 2025Allow4530YesNo
17593559SKIN TREATMENT METHOD USING MEDICAL LASER, HAVING IMPROVED TREATMENT EFFICACYSeptember 2021December 2025Abandon5130NoNo
17439050WEARABLE DEVICE FOR PAIN TREATMENT BY COMPOUND PHOTO-CHEMICAL ACTION PRINCIPLESeptember 2021April 2025Allow4310YesNo
17436135MASK AND SKIN CARE DEVICE INCLUDING SAMESeptember 2021March 2025Allow4310YesNo
17446703WEARABLE LIGHT STIMULATION SYSTEMS AND METHODSSeptember 2021November 2022Abandon1520NoNo
17310776OPTICAL APPLICATOR FEATURE OPTIMIZERAugust 2021January 2024Allow2910NoNo
17382275DISPLAYS WITH THERAPEUTIC-LIGHT EMITTERS AND METHODS OF THEIR USEJuly 2021January 2026Abandon5421NoNo
17377123PORTABLE DEVICE FOR QUANTITATIVE MEASUREMENT OF TISSUE AUTOREGULATION AND NEUROVASCULAR COUPLING USING EEG, METABOLISM, AND BLOOD FLOW DIAGNOSTICSJuly 2021September 2024Allow3901YesNo
17347182PATIENT SUPPORT APPARATUS WITH PATIENT INFORMATION SENSORSJune 2021July 2025Allow4940YesYes
17303960SYSTEMS AND METHODS FOR SYNCHRONIZED THREE-DIMENSIONAL LASER INCISIONSJune 2021March 2024Allow3330NoNo
17339314LASER TREATMENT OF SKIN LESIONS UNDER DERMAL VASOCONSTRICTIONJune 2021March 2024Allow3320NoNo
17329633SYSTEMS FOR PERFORMING ENDOSCOPIC PROCEDURESMay 2021December 2024Abandon4201NoNo
17324011ENHANCING LEFT VENTRICULAR RELAXATION THROUGH NEUROMODULATIONMay 2021December 2022Allow1900YesNo
17236937CONFOCAL LASER EYE SURGERY SYSTEMApril 2021March 2024Abandon3520NoNo
17232036CARDIAC EVENT IDENTIFIER AND SELECTORApril 2021November 2024Abandon4340YesNo
17221415MODULATED WAVEFORM TREATMENT DEVICE AND METHODApril 2021March 2024Allow3520NoNo
17203308COMPONENTRY AND DEVICES FOR LIGHT THERAPY DELIVERY AND METHODS RELATED THERETOMarch 2021May 2022Allow1420YesNo
17196690MODULAR IMPLANT DELIVERY AND POSITIONING SYSTEMMarch 2021February 2024Allow3530NoNo
17267178DELIVERY OF ENERGY TO A TARGET REGION OF A PATIENT'S BODY TO SATISFY THERAPEUTIC REQUIREMENTS PRECISELYFebruary 2021June 2025Abandon5250NoNo
17264927INTRAVASCULAR BLOOD PUMPS AND METHODS OF USEFebruary 2021August 2024Allow4210YesNo
17152263MULTI-MODAL SLEEP SYSTEMJanuary 2021December 2023Abandon3520YesNo
17146849Methods and Systems for Activating Cells to Treat AgingJanuary 2021October 2023Allow3320NoNo
17140655TEMPERATURE SENSING OF IMPLANTED WIRELESS RECHARGE COILJanuary 2021December 2025Allow5930YesNo
17131761BIOLOGICAL INFORMATION MONITORING SYSTEMDecember 2020February 2024Allow3810NoNo
17124718Determination DeviceDecember 2020September 2023Allow3330YesNo
17253357SYSTEMS AND METHODS FOR EVALUATION OF HEALTH SITUATION OR CONDITIONDecember 2020July 2024Allow4310NoNo
17252600LOW POWER RECEIVER FOR IN VIVO CHANNEL SENSING AND INGESTIBLE SENSOR DETECTION WITH WANDERING FREQUENCYDecember 2020September 2023Allow3300NoNo
17252639RE-WEARABLE PHYSIOLOGICAL MONITORING DEVICEDecember 2020December 2024Allow4821YesNo
17106883MACRO/MICRO-STRUCTURE OF SLEEP AND SIMILAR STATES OF CONSCIOUSNESS TO OPTIMIZE PAIN TREATMENTNovember 2020June 2023Allow3020NoNo
17057721APPARATUS AND A METHOD FOR MONITORING A PATIENT DURING HIS SLEEPNovember 2020May 2025Abandon5460NoNo
17061073Method for predicting efficacy of a stimulus by measuring physiological response to stimuliOctober 2020March 2024Abandon4220YesNo
17042678ARM DEVICESeptember 2020February 2025Allow5320YesNo
16948292APPARATUS, SYSTEM AND METHOD FOR CHRONIC DISEASE MONITORINGSeptember 2020November 2023Allow3830YesNo
16978737Mid infrared radiation saunaSeptember 2020December 2023Abandon4010NoNo
16989067Light Therapy ApparatusAugust 2020December 2021Allow1620YesNo
16985113PORTABLE DEVICE FOR QUANTITATIVE MEASUREMENT OF TISSUE AUTOREGULATION AND NEUROVASCULAR COUPLING USING EEG, METABOLISM, AND BLOOD FLOW DIAGNOSTICSAugust 2020September 2021Abandon1320YesNo
16966962OXYTOCIN RELEASE STIMULATIONAugust 2020December 2023Allow4101NoNo
16960679System and Method for Classifying and Modulating Brain Behavioral StatesJuly 2020December 2022Allow3010YesNo
16958525SYNCHRONIZATION OF PHYSIOLOGICAL DATAJune 2020April 2024Allow4650YesNo
16760442HEALTHCARE DEVICE AND HEALTHCARE SYSTEM USING SAMEJune 2020July 2022Abandon2710NoNo
16865379DEVICE AND METHOD FOR FAST ACQUISITION OF VITAL SIGNSMay 2020September 2024Abandon5340NoNo
16760806PHOTOBIOMODULATION THERAPY TO AMELIORATE MULTIPLE SCLEROSISApril 2020June 2022Abandon2540YesNo
16863664WEARABLE LIGHT STIMULATION SYSTEMS AND METHODSApril 2020May 2021Allow1211NoNo
16861622DEVICE AND METHOD FOR USE OF PHOTODYNAMIC THERAPYApril 2020May 2023Abandon3630YesNo
16846551COMPRESSED-SENSING OF SPATIOTEMPORALLY-CORRELATED AND/OR RAKENESS-PROCESSED ELECTROGRAMSApril 2020October 2022Allow3010NoNo
16753508A METHOD AND AN APPARATUS FOR PRODUCING INFORMATION INDICATIVE OF METABOLIC STATEApril 2020September 2022Abandon3010NoNo
16840083AV SYNCHRONOUS VFA CARDIAC THERAPYApril 2020January 2026Abandon6060YesYes
16834770PHOTOTHERAPEUTIC DEVICE FOR A PENIS AND A USING METHOD THEREOFMarch 2020April 2022Abandon2420NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HUH, VYNN V.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
4
Examiner Affirmed
3
(75.0%)
Examiner Reversed
1
(25.0%)
Reversal Percentile
41.9%
Lower than average

What This Means

With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
12
Allowed After Appeal Filing
6
(50.0%)
Not Allowed After Appeal Filing
6
(50.0%)
Filing Benefit Percentile
84.2%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner HUH, VYNN V - Prosecution Strategy Guide

Executive Summary

Examiner HUH, VYNN V works in Art Unit 3792 and has examined 208 patent applications in our dataset. With an allowance rate of 63.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 40 months.

Allowance Patterns

Examiner HUH, VYNN V's allowance rate of 63.9% places them in the 24% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by HUH, VYNN V receive 3.09 office actions before reaching final disposition. This places the examiner in the 88% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HUH, VYNN V is 40 months. This places the examiner in the 25% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +38.5% benefit to allowance rate for applications examined by HUH, VYNN V. This interview benefit is in the 86% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 19.8% of applications are subsequently allowed. This success rate is in the 21% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 15.8% of cases where such amendments are filed. This entry rate is in the 17% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 77% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 69.2% of appeals filed. This is in the 56% percentile among all examiners. Of these withdrawals, 33.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 47.1% are granted (fully or in part). This grant rate is in the 42% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 50% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.